Skip to main content
. 2021 Dec 20;12:715102. doi: 10.3389/fimmu.2021.715102

Table 4.

Summary of findings in the EBV CF+ patient group.

Baseline 6 months
In vitro ↑ RANTES ↑ RANTES
↑ β-agonist response
Plasma ↑ CRP ↑ CRP